{"name":"HBL Hadasit Bio Holdings","permalink":"hbl-hadasit-bio-holdings","crunchbase_url":"http://www.crunchbase.com/financial-organization/hbl-hadasit-bio-holdings","homepage_url":"http://www.hbl.co.il/","blog_url":"","blog_feed_url":"","twitter_username":"","phone_number":"+ 972-2-677-8757 ","description":"Venture Capital Firm","email_address":"info@hbl.co.il","number_of_employees":null,"founded_year":null,"founded_month":null,"founded_day":null,"tag_list":null,"alias_list":"","created_at":"Wed Jul 07 04:26:14 UTC 2010","updated_at":"Sat Sep 18 16:49:47 UTC 2010","overview":"<p>Hadasit Bio-Holdings Ltd. (&#8220;HBL&#8221;) was founded and floated on the Tel Aviv Stock Exchange (TASE : HDST ) in order to allow public participation in the highly promising field of biotechnology.</p>\n\n<p>It serves as a precedent in biotech financing - for the first time, public investment is allowed to participate in a holding entity including companies based on IP generated by Israelâ€™s foremost medical research center â€“ Hadassah University Hospital (&#8220;HU&#8221;).</p>\n\n<p>In addition to the public holdings (53%) â€“ including major Israeli institutional investors, HBL is held by Hadasit (www.hadasit.co.il) (37%) and Consensus Business Group (http://www.consensusbusiness.com) (10%). The traded stock, as a unique investment vehicle, provides investment exposure to a select cluster of 8 biotech companies - all based on inventions developed and owned by HU.</p>\n\n<p>HBL is a publicly traded subsidiary of Hadasit Ltd. â€“ the technology transfer company of the Hadassah University Hospital in Jerusalem, Israel. Hadasit was established for the purpose of promoting and commercializing the intellectual property (IP) and R&amp;D capabilities generated by Hadassah, aimed at finding solutions to problems faced by modern medicine.</p>","image":{"available_sizes":[[[150,62],"assets/images/resized/0010/2214/102214v1-max-150x150.png"],[[185,77],"assets/images/resized/0010/2214/102214v1-max-250x250.png"],[[185,77],"assets/images/resized/0010/2214/102214v1-max-450x450.png"]],"attribution":null},"offices":[{"description":"HQ","address1":"Jerusaelm Bio-Park, 5th Floor  ","address2":"Hadassah Ein-Kerem Campus  ","zip_code":"91120","city":"Jerusalem ","state_code":null,"country_code":"ISR","latitude":null,"longitude":null}],"relationships":[],"investments":[{"funding_round":{"round_code":"a","source_url":"http://www.hbl.co.il/portfolio_company.asp?ID=5","source_description":"ProtAb has recently raised $4M from HBL and two of the largest life science venture capital firms in Israel,","raised_amount":4000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":4,"funded_day":23,"company":{"name":"ProtAb","permalink":"protab","image":{"available_sizes":[[[142,56],"assets/images/resized/0008/4788/84788v1-max-150x150.png"],[[142,56],"assets/images/resized/0008/4788/84788v1-max-250x250.png"],[[142,56],"assets/images/resized/0008/4788/84788v1-max-450x450.png"]],"attribution":null}}}}],"milestones":[],"providerships":[],"funds":[],"video_embeds":[],"external_links":[]}